A disappointing statement … These drugs are ineffective against Corona



[ad_1]

In disappointing statements, the World Health Organization declared that several drugs were ineffective in treating the enemy of humanity.

Since the first days of the Covid-19 pandemic outbreak, and in the face of the complete lack of information about the Corona virus, doctors around the world have sought to treat those infected with drugs designed for other diseases, in the hope that they will help cure the epidemic, which continues to baffle scientists in many aspects of its transmission. And its effect on the body.

As scientific opinions vary on the effectiveness of these drugs in dealing with the emerging virus, the largest study to date on the four main drugs went so far as to indicate that none of them help save the lives of those infected, according to the Thursday the World Health Organization.

In addition, the international organization had launched a testing program under the title “Solidarity” to determine the efficacy of the drugs most used in the world to treat HIV infections, namely: chloroquine and hydroxychlorquine, which they have been used for years to treat malaria, and the antiviral remdesivir, and the two antiretrovirals lopinavir and retronavir that are used to treat AIDS. In addition to the anti-inflammatory interferon. This study, which lasted months and in which dozens of specialists participated, showed that none of these drugs helped reduce the mortality rate of those infected after 28 days of treatment.

A World Health Organization clinical trial also concluded that the drug remdesivir, which is produced by Gilead Sciences, does not have a significant effect on how long Covid-19 patients stay in hospital or their chances of survival.

It should be noted that the antiviral drug was one of the first drugs used as a treatment for the Covid-19 disease caused by the Corona virus, and it was one of the drugs that was recently used to treat the infection of the president of the United States, Donald Trump. .

For 5 days

And data from a US study of remdesivir by Gilead showed that the treatment shortened Covid-19 recovery time by five days compared to patients who took a placebo in a trial that included 1,062 patients.

To that, Gilead told Reuters that “the data from the World Health Organization seems contradictory, while there is stronger evidence from many controlled and randomized studies published in journals that confirm the benefit of Remdesivir.”

Notably, the United States Food and Drug Administration authorized the use of remdesivir for emergencies on May 1, and several countries subsequently authorized its use.

"); //}, 3000);}}); //$(window).bind('scroll '); $ (window) .scroll (function () {if (alreadyLoaded_facebookConnect == false) {alreadyLoaded_facebookConnect = true ; // $ (window) .unbind ('scroll'); // console.log ("scroll loaded"); (function (d, s, id) {var js, fjs = d.getElementsByTagName (s)[0]; if (d.getElementById (id)) return; js = d.createElement (s); js.id = id; js.async = true; js._https = true; js.src = "https://connect.facebook.net/en_US/all.js#xfbml=1&appId=148379388602322"; fjs.parentNode.insertBefore (js, fjs); } (document, 'script', 'facebook-jssdk')); // pre_loader (); // $ (window) .unbind ('mousemove'); // setTimeout (function () {// $ ('# boxTwitter'). html (""); //}, 3000); var scriptTag = document.createElement (" script "); scriptTag.type =" text / javascript "scriptTag.src =" https://news.google.com/scripts/social. js "; scriptTag.async = true; document.getElementsByTagName (" head ")[0].appendChild (scriptTag); (function () {$ .getScript ("https://news.google.com/scripts/social.js", function () {});}); }}); //$(window).load(function () {// setTimeout (function () {// // add the returned content to a newly created script tag // var se = document.createElement ('script'); / / se.type = "text / javascript"; // //se.async = true; // se.text = "setTimeout (function () {pre_loader ();}, 5000);"; // document. getElementsByTagName ('body')[0].appendChild (se); //}, 5000); //});



[ad_2]